Next, the FDA must decide whether to authorize the protein vaccine made by latecomer Novavax as the nation’s fourth coronavirus shot for adults. Read More
Novavax COVID shot is approved by FDA advisers, raising possibility of a fourth U.S. vaccine option
ByHarry
Jun 7, 2022